These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6271425)

  • 21. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
    Nicholson CD; Shahid M
    Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.
    Chasin M; Scott C
    Biochem Pharmacol; 1978; 27(16):2065-7. PubMed ID: 214090
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacodynamic aspects of theophylline].
    Marmo E
    Clin Ter; 1983 Jul; 106(2):87-94. PubMed ID: 6313282
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
    Donnelly TE; Barron B
    Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
    Frossard N; Landry Y; Pauli G; Ruckstuhl M
    Br J Pharmacol; 1981 Aug; 73(4):933-8. PubMed ID: 6168323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Murray KJ; England PJ
    Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of human lymphocyte cyclic nucleotide phosphodiesterases by the chlorinated adenosine analog DTA-35.
    Hurwitz MY; Hurwitz RL; Edstrom RD
    J Enzyme Inhib; 1987; 1(4):267-74. PubMed ID: 2854846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors.
    Ruckstuhl M; Beretz A; Anton R; Landry Y
    Biochem Pharmacol; 1979; 28(4):535-8. PubMed ID: 218594
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Fitzpatrick DF; Szentivanyi A
    Biochem Pharmacol; 1978 Jan; 27(2):254-6. PubMed ID: 203292
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of polyphloretin phosphate (PPP) and quinterenol of cyclic nucleotide phosphodiesterase activities.
    Curtis-Prior PB; Chan YH
    Pharmacol Res Commun; 1981 Apr; 13(4):331-7. PubMed ID: 6270700
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes.
    Aleksijevic A; Lugnier C; Giron C; Mayer S; Stoclet JC; Lang JM
    Int J Immunopharmacol; 1987; 9(5):525-31. PubMed ID: 3040609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of theophylline on concentrations of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate of rat brain.
    Stefanovich V
    Neurochem Res; 1979 Oct; 4(5):587-94. PubMed ID: 226900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.
    Francis SH; Sekhar KR; Ke H; Corbin JD
    Handb Exp Pharmacol; 2011; (200):93-133. PubMed ID: 20859794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.
    Ruckstuhl M; Landry Y
    Biochem Pharmacol; 1981 Apr; 30(7):697-702. PubMed ID: 6264919
    [No Abstract]   [Full Text] [Related]  

  • 39. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
    Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
    [No Abstract]   [Full Text] [Related]  

  • 40. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.